BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 31612868)

  • 1. Telomere clustering drives ALT.
    Min J; Shay JW
    Aging (Albany NY); 2019 Oct; 11(19):8046-8047. PubMed ID: 31612868
    [No Abstract]   [Full Text] [Related]  

  • 2. Clustered telomeres in phase-separated nuclear condensates engage mitotic DNA synthesis through BLM and RAD52.
    Min J; Wright WE; Shay JW
    Genes Dev; 2019 Jul; 33(13-14):814-827. PubMed ID: 31171703
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Surviving Telomere Attrition with the MiDAS Touch.
    Flynn RL; Heaphy CM
    Trends Genet; 2019 Nov; 35(11):783-785. PubMed ID: 31526614
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Alternative Lengthening of Telomeres Mediated by Mitotic DNA Synthesis Engages Break-Induced Replication Processes.
    Min J; Wright WE; Shay JW
    Mol Cell Biol; 2017 Oct; 37(20):. PubMed ID: 28760773
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Telomere length heterogeneity in ALT cells is maintained by PML-dependent localization of the BTR complex to telomeres.
    Loe TK; Li JSZ; Zhang Y; Azeroglu B; Boddy MN; Denchi EL
    Genes Dev; 2020 May; 34(9-10):650-662. PubMed ID: 32217664
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alternative Lengthening of Telomeres through Two Distinct Break-Induced Replication Pathways.
    Zhang JM; Yadav T; Ouyang J; Lan L; Zou L
    Cell Rep; 2019 Jan; 26(4):955-968.e3. PubMed ID: 30673617
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nuclear body phase separation drives telomere clustering in ALT cancer cells.
    Zhang H; Zhao R; Tones J; Liu M; Dilley RL; Chenoweth DM; Greenberg RA; Lampson MA
    Mol Biol Cell; 2020 Aug; 31(18):2048-2056. PubMed ID: 32579423
    [TBL] [Abstract][Full Text] [Related]  

  • 8. FANCM suppresses DNA replication stress at ALT telomeres by disrupting TERRA R-loops.
    Pan X; Chen Y; Biju B; Ahmed N; Kong J; Goldenberg M; Huang J; Mohan N; Klosek S; Parsa K; Guh CY; Lu R; Pickett HA; Chu HP; Zhang D
    Sci Rep; 2019 Dec; 9(1):19110. PubMed ID: 31836759
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The telomere-associated homeobox-containing protein TAH1/HMBOX1 participates in telomere maintenance in ALT cells.
    Feng X; Luo Z; Jiang S; Li F; Han X; Hu Y; Wang D; Zhao Y; Ma W; Liu D; Huang J; Songyang Z
    J Cell Sci; 2013 Sep; 126(Pt 17):3982-9. PubMed ID: 23813958
    [TBL] [Abstract][Full Text] [Related]  

  • 10. FANCD2 limits BLM-dependent telomere instability in the alternative lengthening of telomeres pathway.
    Root H; Larsen A; Komosa M; Al-Azri F; Li R; Bazett-Jones DP; Stephen Meyn M
    Hum Mol Genet; 2016 Aug; 25(15):3255-3268. PubMed ID: 27427384
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Augmented telomerase activity, reduced telomere length and the presence of alternative lengthening of telomere in renal cell carcinoma: plausible predictive and diagnostic markers.
    Pal D; Sharma U; Khajuria R; Singh SK; Kakkar N; Prasad R
    Gene; 2015 May; 562(2):145-51. PubMed ID: 25769384
    [TBL] [Abstract][Full Text] [Related]  

  • 12. WRN loss induces switching of telomerase-independent mechanisms of telomere elongation.
    Gocha AR; Acharya S; Groden J
    PLoS One; 2014; 9(4):e93991. PubMed ID: 24709898
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Telomere Length Maintenance in Cancer: At the Crossroad between Telomerase and Alternative Lengthening of Telomeres (ALT).
    De Vitis M; Berardinelli F; Sgura A
    Int J Mol Sci; 2018 Feb; 19(2):. PubMed ID: 29463031
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alternative Lengthening of Telomeres (ALT) in Tumors and Pluripotent Stem Cells.
    Zhao S; Wang F; Liu L
    Genes (Basel); 2019 Dec; 10(12):. PubMed ID: 31835618
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alternative lengthening of telomeres can be maintained by preferential elongation of lagging strands.
    Min J; Wright WE; Shay JW
    Nucleic Acids Res; 2017 Mar; 45(5):2615-2628. PubMed ID: 28082393
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ALT-associated PML bodies are present in viable cells and are enriched in cells in the G(2)/M phase of the cell cycle.
    Grobelny JV; Godwin AK; Broccoli D
    J Cell Sci; 2000 Dec; 113 Pt 24():4577-85. PubMed ID: 11082050
    [TBL] [Abstract][Full Text] [Related]  

  • 17. TRF1 phosphorylation on T271 modulates telomerase-dependent telomere length maintenance as well as the formation of ALT-associated PML bodies.
    Ho A; Wilson FR; Peragine SL; Jeyanthan K; Mitchell TR; Zhu XD
    Sci Rep; 2016 Nov; 6():36913. PubMed ID: 27841304
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Probing PML body function in ALT cells reveals spatiotemporal requirements for telomere recombination.
    Draskovic I; Arnoult N; Steiner V; Bacchetti S; Lomonte P; LondoƱo-Vallejo A
    Proc Natl Acad Sci U S A; 2009 Sep; 106(37):15726-31. PubMed ID: 19717459
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Telomerase suppresses formation of ALT-associated single-stranded telomeric C-circles.
    Plantinga MJ; Pascarelli KM; Merkel AS; Lazar AJ; von Mehren M; Lev D; Broccoli D
    Mol Cancer Res; 2013 Jun; 11(6):557-67. PubMed ID: 23505069
    [TBL] [Abstract][Full Text] [Related]  

  • 20. XPF activates break-induced telomere synthesis.
    Guh CY; Shen HJ; Chen LW; Chiu PC; Liao IH; Lo CC; Chen Y; Hsieh YH; Chang TC; Yen CP; Chen YY; Chen TW; Chen LY; Wu CS; Egly JM; Chu HC
    Nat Commun; 2022 Oct; 13(1):5781. PubMed ID: 36184605
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.